Expert Interviews in Dyslipidemia and Atherosclerosis - 2018 CMHC West

PROGRAM DESCRIPTION This educational activity is comprised of a collection of 4 expert commentary interviews that highlight the most pertinent content from the Dyslipidemia/Atherosclerosis Session at the 2018 CMHC West ...

PROGRAM DESCRIPTION
This educational activity is comprised of a collection of 4 expert commentary interviews that highlight the most pertinent content from the Dyslipidemia/Atherosclerosis Session at the 2018 CMHC West meeting. As heart disease is the leading cause of death in the Unites States, healthcare providers can play a major role in stemming the future burden of cardiovascular disease by employing strategies for the early identification and comprehensive management of patients presenting with multiple cardiometabolic risk factors. The following 4 modules will equip healthcare providers with the knowledge necessary to address these clinical challenges:Module 1: Triglycerides and Cardiovascular DiseaseModule 2: Familial Hypercholesterolemia: Identification and ManagementModule 3: Importance of Lifestyle Modifications and Incorporation into Clinical PracticeModule 4: Non-Statin Drugs and New ApproachesDownloadable transcripts and slides will also be provided to learners.

EDUCATIONAL OBJECTIVES
Upon completion of this activity, participants should be able to:Identify appropriate lipid management strategies for patients at high risk of ASCVDDescribe the efficacy and safety of current and emerging agents for dyslipidemiaReview the latest published guidelines and recommendations for lipid management, including pharmacotherapy and lifestyle modifications

---

Write the first review

Resource tags